跳至主要内容
临床试验/ACTRN12621001242819
ACTRN12621001242819尚未招募2 期

Pilot Study Evaluation of a Combination of Topical 5-Fluorouracil [5FU] and Calcipotriol in the Treatment of Cutaneous Actinic Keratosis [AK] and Intraepidermal Carcinoma [IEC] Lesions

Dr Leith Banney0 个研究点目标入组 30 人开始时间: 2021年9月15日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Adults aged 18-85 years.
  • Extensive solar damage to skin over the face, as determined by a dermatologist.
  • Ability to comply with treatment regime as determined by the treating investigator.
  • Ability to undertake written informed consent prior to initiation of study protocol.
  • Ability/willing to attend follow up clinic visits that will include clinical photography.
  • Able to complete study surveys.

排除标准

  • Patients commencing acitretin, other oral or topical retinoids or oral vitamin B3 in the past 3 months and for the duration of the study.
  • Patients with known allergy/hypersensitivity to 5FU cream.
  • Patients with known dihydropyrimidine dehydrogenase (DPD enzyme) deficiency.
  • Patients who are pregnant or breastfeeding. Female participants should avoid pregnancy and breastfeeding during use of treatment cream until three-month review.

研究者

发起方
Dr Leith Banney

相似试验